IRB Approval. Company agrees to obtain prior written approval from each clinical site’s Institutional Review Board (“IRB”) before undertaking any clinical trial with human subject research as required by applicable law. A true copy of the executed copy of this approval must be made available within ten (10) days upon written request by LLS.
Appears in 3 contracts
Sources: Definitive Agreement, Definitive Agreement (Celator Pharmaceuticals Inc), Definitive Agreement (Celator Pharmaceuticals Inc)
IRB Approval. Company agrees to obtain prior written approval from each clinical site’s Institutional Review Board (“IRB”) before undertaking any clinical trial with human subject research as required by applicable law. A true copy of the executed copy of this approval must be made available within ten (10) ** days upon written request by LLS.
Appears in 2 contracts
Sources: Definitive Agreement (Onconova Therapeutics, Inc.), Definitive Agreement (Onconova Therapeutics, Inc.)
IRB Approval. Company agrees to obtain prior written approval from each clinical site’s Institutional Review Board (“IRB”) IRB before undertaking any clinical trial with human subject research as required by applicable law. A true copy of the executed copy of this approval must be made available within ten (10) [**] days upon written request by LLS.
Appears in 1 contract
Sources: Definitive Agreement (Curis Inc)